GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-7.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$227M
AUM Growth
+$227M
(-39%)
Cap. Flow
-$74.2M
Cap. Flow
% of AUM
-32.73%
Top 10 Holdings %
Top 10 Hldgs %
57.37%
Holding
63
New
13
Increased
10
Reduced
18
Closed
16
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$7.41M |
| 2 |
Mersana Therapeutics
MRSN
|
$7M |
| 3 |
Verastem
VSTM
|
$3.96M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.71M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$3.69M |
Top Sells
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.9M |
| 2 |
Amicus Therapeutics
FOLD
|
$12.2M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$12M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$8.98M |
| 5 |
Sarepta Therapeutics
SRPT
|
$8.39M |
Sector Composition
| 1 | Healthcare | 90.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $20.4M | 5.42% | 650,000 +74,500 | +13% | +$2.34M |
|
2
Ascendis Pharma
ASND
$11.8B
| $16.9M | 4.48% | 150,000 -50,000 | -25% | -$5.63M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $14.2M | 3.75% | 1,050,000 +550,000 | +110% | +$7.41M |
|
4
Adverum Biotechnologies
ADVM
$64.6M
| $12.8M | 3.38% | 1,305,500 +130,500 | +11% | +$1.28M |
|
5
Axsome Therapeutics
AXSM
$6.05B
| $12.6M | 3.35% | 215,000 +15,000 | +8% | +$882K |
|
|
6
Mersana Therapeutics
MRSN
$36.5M
| $11.7M | 3.09% | 2,000,000 +1,200,000 | +150% | +$7M |
|
7
Immunovant
IMVT
$2.56B
| $11.1M | 2.93% | 710,000 -90,000 | -11% | -$1.4M |
|
|
MNTA
8
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.9M | 2.89% | 400,000 | – | – |
|
|
9
Iovance Biotherapeutics
IOVA
$807M
| $10.5M | 2.78% | 350,000 -300,000 | -46% | -$8.98M |
|
10
Rocket Pharmaceuticals
RCKT
$354M
| $9.07M | 2.41% | 650,000 -50,000 | -7% | -$698K |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.84M | 2.34% | 115,000 -35,000 | -23% | -$2.69M |
|
|
RETA
12
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.22M | 1.91% | 50,000 -25,000 | -33% | -$3.61M |
|
13
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.8M | 1.54% | 400,000 -200,000 | -33% | -$2.9M |
|
14
Fate Therapeutics
FATE
$120M
| $5M | 1.33% | 225,000 -50,000 | -18% | -$1.11M |
|
|
MYOV
15
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.42M | 1.17% | 585,000 +135,000 | +30% | +$1.02M |
|
16
Cartesian Therapeutics
RNAC
$261M
| $4.16M | 1.1% | 1,725,000 +575,000 | +50% | +$1.39M |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4M | 1.06% | 2,000,000 -1,000,000 | -33% | -$2M |
|
|
18
Verastem
VSTM
$569M
| $3.96M | 1.05% | +1,500,000 | New | +$3.96M |
|
|
ZGNX
19
DELISTED
Zogenix, Inc.
ZGNX
| $3.71M | 0.98% | +150,000 | New | +$3.71M |
|
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $3.69M | 0.98% | +325,000 | New | +$3.69M |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.33M | 0.88% | +825,000 | New | +$3.33M |
|
22
Arvinas
ARVN
$568M
| $3.22M | 0.86% | 80,000 -145,000 | -64% | -$5.84M |
|
23
Q32 Bio
QTTB
$20.9M
| $3.11M | 0.82% | +200,000 | New | +$3.11M |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.85M | 0.76% | 828,459 +78,459 | +10% | +$270K |
|
|
AVDL
25
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.78M | 0.74% | +350,000 | New | +$2.78M |
|